Results
chronic stroke, stroke
ADVERSE EVENTS, STROKE, SECONDARY
Twenty-nine participants completed the MARS training protocol between April 2021 and July 2022. Four of them were not able to perform ‘10 m walk test’ on day 0 so they were excluded from the final analysis. Twenty-five patients who were included in the final analysis were stratified into two groups based on the stroke duration; sub-acute (≥ 3 weeks to ≤ 6 month) and chronic stroke (> 6 month). The demographic characteristics of all participants are enumerated in Table Baseline characteristics of sub-acute and chronic stroke patientsAll patients completed overground robotics training with MARS and no adverse events were reported. There were statistically significant improvements (Comparison of primary outcome measures before and after intervention in both groups10MWT = 10 Meter walk test, 6MWT = 6 min walk test, 2MWT = 2 min walk test, TUG = Timed Up and Go testChanges in walking ability and function were evaluated using FAC. Table Comparison of secondary outcome measures before and after intervention in both groupsThe difference in scores of primary outcomes was calculated for each participant. The mean and median change of the above scores in both groups was computed. The pre-post score change and MCID (Minimal clinically important difference) and MDC (Minimum Detectable Change) are tabulated in Table The primary outcomes scores (pre and post intervention). [MCID (Minimal clinically important difference) and MDC (minimal detectable change)]10MWT = 10 Meter walk test, 6MWT = 6 min walk test, 2MWT = 2 min walk test, TUG = Timed Up and Go test